Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.
about
The hematopoietic stem cell transplantation in Indonesia: an unsolved dilemma.Non-myeloablative stem cell transplants.Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.An anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitutionNonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.The war on cancer: a report from the front linesPharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.Non-myeloablative allogeneic hematopoietic stem cell transplantation.Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectorsAllogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.Older patients with high-risk fungal infections can be successfully allografted using non-myeloablative conditioning in combination with intensified supportive care regimens.Full chimerism in nonmyeloablative stem cell transplantation in a beta-thalassemia major patient (class 3 Lucarelli).Nonmyeloablative stem cell transplantation with a haploidentical donor in a class 3 lucarelli severe thalassemia patient.
P2860
Q33362904-2DF3AEE3-B5A6-4DB3-ABDF-F4FC398C5965Q34089106-25EE56BB-42F0-4DA6-8029-FD7C32F4C6E0Q34526368-D7412FE2-4553-4F02-BDE4-2AD6E1E15AB9Q34989247-A466AE52-F8F5-4F8B-B775-7A1B8DA5CB12Q35022491-B87A37E8-4A9F-435E-9798-9CDF370DFB78Q35103643-7D038DC0-EBD1-40BD-9351-E31DDB874017Q35848175-BD6DEC94-7589-4843-9733-A7E66E83B0CAQ36231758-E7EBFCC2-8006-4679-BC7D-A5B7359B1BAFQ37308127-9754C7E3-97B8-43A0-A127-817136796B38Q38488058-C76C65AB-1014-4D10-8C2E-F2F52A2B366AQ39025319-04AF95C2-C6F1-4CCD-A9C7-1F73BBF8C333Q40548332-C398B110-63F9-4DA1-B9A0-2445BA2AAE73Q43622711-A5906AF2-45E6-4A2E-BEAE-F6A36A59DBBCQ44139136-98EEB4A4-853E-4CC2-BDFB-0CA024B0A0E2Q44915683-7D5FACF9-7249-4578-AB89-0BAE11302569
P2860
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@ast
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@nl
type
label
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@ast
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@nl
prefLabel
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@ast
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@nl
P2093
P1476
Reinventing bone marrow transp ...... on of graft-versus-malignancy.
@en
P2093
P356
10.1097/00001622-199903000-00003
P577
1999-03-01T00:00:00Z